Literature DB >> 11050144

Dopamine release and uptake dynamics within nonhuman primate striatum in vitro.

S J Cragg1, C J Hille, S A Greenfield.   

Abstract

The putamen of the human striatum is a heterogeneous nucleus that contains the primary site of loss of dopamine (DA) in Parkinson's disease (PD). Furthermore, different functional domains of the putamen are heterogeneously susceptible to DA loss, and yet the dynamic regulation of extracellular DA concentration ([DA](o)) and comparison between domains has not been explored in the primate brain. In these studies, DA was measured in real time using fast-scan cyclic voltammetry at a carbon-fiber microelectrode in vitro in striatal sections from the common marmoset (Callithrix jacchus). [DA](o) released by a single stimulus pulse varied threefold along a ventromedial-dorsolateral axis. DA uptake was via the DA transporter (GBR12909 sensitive, desipramine insensitive). On the basis of data modeling with simulations of Michaelis-Menten kinetics, rate maximum, V(max), varied with region: both [DA](o) and V(max) were greatest in regions most vulnerable in PD. These differences were reflected in part by regional variation in DA content. [DA](o), V(max), and regional variation were two- to threefold greater than in rodent caudatoputamen. In addition, steady-state [DA](o) at physiological firing rates in primate striatum was controlled by depolarization frequency, uptake, and presynaptic autoreceptors. Furthermore, regulation of [DA](o) by these mechanisms differed significantly between limbic- and motor-associated domains. These data indicate interspecies heterogeneity in striatal DA dynamics that must be considered when extrapolating behavioral and drug responses from rodent to the primate brain. Moreover, the heterogeneity demonstrated within the primate putamen in the availability and dynamic regulation of DA may be central to understanding DA function in health, cocaine abuse, and disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050144      PMCID: PMC6772736     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  66 in total

1.  Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate.

Authors:  N R McFarland; S N Haber
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys.

Authors:  C W Bradberry; R L Barrett-Larimore; P Jatlow; S R Rubino
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

4.  Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

5.  An autoradiographic analysis of the efferent connections from premotor and adjacent prefrontal regions (areas 6 and 9) in macaca fascicularis.

Authors:  H Künzle
Journal:  Brain Behav Evol       Date:  1978       Impact factor: 1.808

6.  Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

Authors:  E Carboni; G L Tanda; R Frau; G Di Chiara
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

Review 7.  Presynaptic excitability.

Authors:  M B Jackson
Journal:  Int Rev Neurobiol       Date:  1995       Impact factor: 3.230

Review 8.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

9.  Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.

Authors:  S N Haber; H Ryoo; C Cox; W Lu
Journal:  J Comp Neurol       Date:  1995-11-20       Impact factor: 3.215

10.  Low dopamine transporter mRNA levels in midbrain regions containing calbindin.

Authors:  M K Sanghera; K F Manaye; C L Liang; A M Lacopino; M J Bannon; D C German
Journal:  Neuroreport       Date:  1994-08-15       Impact factor: 1.837

View more
  41 in total

1.  Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

Authors:  Q Wu; M E Reith; M J Kuhar; F I Carroll; P A Garris
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.

Authors:  B Liss; O Franz; S Sewing; R Bruns; H Neuhoff; J Roeper
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 3.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

Review 4.  Electrochemical Analysis of Neurotransmitters.

Authors:  Elizabeth S Bucher; R Mark Wightman
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-05-04       Impact factor: 10.745

Review 5.  Striatal action-learning based on dopamine concentration.

Authors:  Genela Morris; Robert Schmidt; Hagai Bergman
Journal:  Exp Brain Res       Date:  2009-11-11       Impact factor: 1.972

6.  Amphetamine potency varies with dopamine uptake rate across striatal subregions.

Authors:  Cody A Siciliano; Erin S Calipari; Sara R Jones
Journal:  J Neurochem       Date:  2014-07-30       Impact factor: 5.372

Review 7.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

8.  Instrumentation for electrochemical performance characterization of neural electrodes.

Authors:  Michael P Marsh; James N Kruchowski; Seth A Hara; Malcom B McIntosh; Renae M Forsman; Terry L Reed; Christopher Kimble; Kendall H Lee; Kevin E Bennet; Jonathan R Tomshine
Journal:  Rev Sci Instrum       Date:  2017-08       Impact factor: 1.523

9.  Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.

Authors:  Xiomara A Perez; Kathryn T O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2009-01-14       Impact factor: 4.436

10.  Striatal dopamine dynamics in mice following acute and repeated toluene exposure.

Authors:  Aaron K Apawu; Tiffany A Mathews; Scott E Bowen
Journal:  Psychopharmacology (Berl)       Date:  2014-07-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.